Mark L. Fuerst

Dec 11, 2023 | focusononcology.com | Mark L. Fuerst

By Mark L. FuerstIbrutinib plus venetoclax significantly improved responses, progression-free survival (PFS), and overall survival (OS) compared to standard chemoimmunotherapy in fit patients with previously untreated chronic lymphocytic leukemia (CLL).

Dec 10, 2023 | focusononcology.com | Mark L. Fuerst

By Mark L. Fuerst A combination of navitoclax and ruxolitinib led to a clinically significant reduction in spleen size in patients with untreated myelofibrosis (MF), according to the results of a randomized, double-blind, placebo-controlled, multicenter, international Phase III trial.

Dec 9, 2023 | focusononcology.com | Mark L. Fuerst

AI Differentiates Prefibrotic Primary Myelofibrosis from Essential Thrombocythemia By Mark L. Fuerst A novel artificial intelligence (AI) model can quickly distinguish between prefibrotic primary myelofibrosis (PMF) and essential thrombocythemia (ET) with high accuracy in distinct clinical cohorts. The model, previously trained on more than 32,000 pan-cancer biopsy images that has learned general pathological features, is the largest test to use AI to differentiate between prefibrotic PMF and ET.

Sep 7, 2023 | renalandurologynews.com | Mark L. Fuerst

Since Elon Musk bought Twitter in October 2022, the site has seen a lot of changes, including a recent rebranding to “X.”1Many of the changes — such as charging for verification, limiting the number of tweets users can read, and preventing them from retweeting certain posts — have prompted some users to migrate to other social media platforms.1-5There’s been widespread speculation that users will continue to leave and Twitter will go the way of sites like MySpace and Vine.

Sep 6, 2023 | hematologyadvisor.com | Mark L. Fuerst

Since Elon Musk bought Twitter in October 2022, the site has seen a lot of changes, including a recent rebranding to “X.”1Many of the changes — such as charging for verification, limiting the number of tweets users can read, and preventing them from retweeting certain posts — have prompted some users to migrate to other social media platforms.1-5There’s been widespread speculation that users will continue to leave and Twitter will go the way of sites like MySpace and Vine.